Radiomics based on 18F-FDG PET/CT for prediction of pathological complete response to neoadjuvant therapy in non-small cell lung cancer
View abstract on PubMed
Summary
This summary is machine-generated.This study shows that combining 18F-FDG PET/CT radiomics with clinicopathological data improves prediction of pathological complete response (pCR) to neoadjuvant therapy (NAT) for non-small cell lung cancer (NSCLC). The integrated support vector machine model achieved high accuracy, aiding clinical decisions.
Area Of Science
- Oncology
- Radiology
- Medical Imaging
Background
- Non-small cell lung cancer (NSCLC) treatment response prediction is crucial.
- Neoadjuvant therapy (NAT) is a standard treatment for NSCLC.
- Accurate prediction of pathological complete response (pCR) to NAT can guide treatment decisions.
Purpose Of The Study
- To develop and evaluate integrated models for predicting pCR to NAT in NSCLC.
- To assess the value of 18F-FDG PET/CT-based radiomics combined with clinicopathological information.
- To compare the performance of different radiomic and integrated models.
Main Methods
- 106 NSCLC patients undergoing NAT were included.
- 2,016 PET-based and 2,016 CT-based radiomic features were extracted after VOI segmentation.
- 25 machine learning models were constructed using various classifiers and feature sets (PET, CT, PET/CT radiomics, clinicopathological data, and integrated data).
- Model performance was evaluated using Area Under the Curves (AUC) from Receiver Operator Characteristic (ROC) curves.
Main Results
- The hybrid PET/CT radiomic model outperformed PET-alone and CT-alone models for pCR prediction.
- Integrating clinicopathological information further improved the predictive performance of the PET/CT radiomic model.
- The support vector machine (SVM)-based model combining PET/CT radiomics and clinicopathological data achieved the highest AUC (0.925 training, 0.863 test).
Conclusions
- Integrated 18F-FDG PET/CT radiomics and clinicopathological information provide an optimal model for non-invasively predicting pCR to NAT in NSCLC.
- The developed SVM-based model demonstrates high predictive efficacy.
- A nomogram incorporating radiomics and pathological type can facilitate clinical application.
Related Concept Videos
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Radioactive Tracer: PET involves using biologically active molecules labeled with radioactive isotopes, known as tracers or radiotracers. The...

